216 related articles for article (PubMed ID: 8942941)
1. [Alkaline phosphatase of bone origin in hemodialyzed patients. 110 assays].
Ureña P; Prieur P; Pétrover M
Presse Med; 1996 Oct; 25(29):1320-5. PubMed ID: 8942941
[TBL] [Abstract][Full Text] [Related]
2. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.
Ureña P; Hruby M; Ferreira A; Ang KS; de Vernejoul MC
J Am Soc Nephrol; 1996 Mar; 7(3):506-12. PubMed ID: 8704118
[TBL] [Abstract][Full Text] [Related]
3. [Interest of bone alkaline phosphatase in hemodialysis patients].
Helal I; Bahlous A; El Younsi F; Ben Hamida F; Abdelmoula J; Belkahia C; Kheder A
Tunis Med; 2008 May; 86(5):427-30. PubMed ID: 19469294
[TBL] [Abstract][Full Text] [Related]
4. Plasma bone-specific alkaline phosphatase changes in hemodialysis patients treated by alfacalcidol.
Ureña P; Bernard-Poenaru O; Cohen-Solal M; de Vernejoul MC
Clin Nephrol; 2002 Apr; 57(4):261-73. PubMed ID: 12005242
[TBL] [Abstract][Full Text] [Related]
5. Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy.
Fujimori A; Sakai M; Yoshiya K; Shin J; Kim JI; Inaba Y; Miyamoto T; Inoue S; Fukagawa M
Ther Apher Dial; 2004 Dec; 8(6):474-9. PubMed ID: 15663547
[TBL] [Abstract][Full Text] [Related]
6. Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism.
Lu KC; Tseng CF; Wu CC; Yeung LK; Chen JS; Chao TY; Janckila AJ; Yam LT; Chu P
Blood Purif; 2006; 24(5-6):423-30. PubMed ID: 16888370
[TBL] [Abstract][Full Text] [Related]
7. Bone alkaline phosphatase besides intact parathyroid hormone in hemodialysis patients--any advantage?
Jorge C; Gil C; Possante M; Silva E; Andrade R; Santos N; Cruz A; Teixeira R; Ferreira A
Nephron Clin Pract; 2005; 101(3):c122-7. PubMed ID: 16015001
[TBL] [Abstract][Full Text] [Related]
8. [Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].
Jarava C; Armas JR; Palma A
Nefrologia; 2000; 20(4):362-72. PubMed ID: 11039262
[TBL] [Abstract][Full Text] [Related]
9. Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients.
Kobayashi I; Shidara K; Okuno S; Yamada S; Imanishi Y; Mori K; Ishimura E; Shoji S; Yamakawa T; Inaba M
Life Sci; 2012 Jan; 90(5-6):212-8. PubMed ID: 22154904
[TBL] [Abstract][Full Text] [Related]
10. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.
Fletcher S; Jones RG; Rayner HC; Harnden P; Hordon LD; Aaron JE; Oldroyd B; Brownjohn AM; Turney JH; Smith MA
Nephron; 1997; 75(4):412-9. PubMed ID: 9127327
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: a randomized prospective multicentre trial.
Hayashi M; Tsuchiya Y; Itaya Y; Takenaka T; Kobayashi K; Yoshizawa M; Nakamura R; Monkawa T; Ichihara A
Nephrol Dial Transplant; 2004 Aug; 19(8):2067-73. PubMed ID: 15187195
[TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
13. Decreased blood lead levels after calcitriol treatment in hemodialysis patients with secondary hyperparathyroidism.
Lu KC; Wu CC; Ma WY; Chen CC; Wu HC; Chu P
Bone; 2011 Dec; 49(6):1306-10. PubMed ID: 21985997
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
[TBL] [Abstract][Full Text] [Related]
15. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
Coen G; Ballanti P; Bonucci E; Calabria S; Centorrino M; Fassino V; Manni M; Mantella D; Mazzaferro S; Napoletano I; Sardella D; Taggi F
Nephrol Dial Transplant; 1998 Sep; 13(9):2294-302. PubMed ID: 9761512
[TBL] [Abstract][Full Text] [Related]
16. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism.
Lu KC; Ma WY; Yu JC; Wu CC; Chu P
Clin Endocrinol (Oxf); 2012 May; 76(5):634-42. PubMed ID: 22007930
[TBL] [Abstract][Full Text] [Related]
17. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
[TBL] [Abstract][Full Text] [Related]
18. Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients.
Moore C; Yee J; Malluche H; Rao DS; Monier-Faugere MC; Adams E; Daramola-Ogunwuyi O; Fehmi H; Bhat S; Osman-Malik Y
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1484-1493. PubMed ID: 19713297
[TBL] [Abstract][Full Text] [Related]
19. Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience.
Liangos O; Kirchhoff S; Buchholz J; Ketteler M
Kidney Blood Press Res; 2018; 43(4):1222-1230. PubMed ID: 30071519
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis].
Rojas González AM; Opazo Valenzuela M; Muñoz Navarro S
Medwave; 2014 Sep; 14(8):e6014. PubMed ID: 25340338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
